The company is a subsidiary of Sichuan Crane Pharmaceutical Co., one of the largest infusion manufacturers in the world. The production site of antibiotic intermediates in Yining city will produce erythromycin thiocyanate and cephalosporin intermediates. Production scale is targeted for 13.800 tons of antibiotic intermediates by 2014, and investment is 4,8 billion RMB.

Xinjiang Daily, August 21, 2012